Results for tag: PD-L1 Total Items Found: 16

Nadeem Riaz on Established and Emerging Biomarkers for Immunotherapy in Head and Neck Cancer

Type of Page:TapVideo
Edit This Item
Tags for this item:
biomarkers
combined positive score
cps
head and neck cancers symposium
immunotherapy
microsatellite instability
pd-l1
predictive biomarker
prognostic biomarker
tumor mutational burden

Created: 3/3/2020 7:06:00 PM

Hope Rugo on a Retrospective Analysis of PD-L1 Immunohistochemistry Assays

Type of Page:TapVideo
Edit This Item
Tags for this item:
san antonio breast cancer symposium
assays
immunohistochemistry
pd-l1
breast cancer
tnbc
triple-negative breast cancer
atezolizumab
nab-paclitaxel

Created: 1/13/2020 10:42:08 PM

Edward Garon on KEYNOTE-001 Trial of Pembrolizumab in NSCLC

Type of Page:TapVideo
Edit This Item
Tags for this item:
asco 2019
keynote-001
lung cancer
NSCLC
pd-l1
pembrolizumab

Created: 6/1/2019 5:09:44 PM

Matthew Gubens on the NSCLC NCCN Guidelines

Type of Page:TapVideo
Edit This Item
Tags for this item:
nccn
nsclc
pembrolizumab
genetic mutations
NCCN guidelines
non-small cell lung cancer
nonsquamous
pd-l1
squamous

Created: 3/21/2019 7:09:52 PM

Martin Reck on Immunotherapy for Thoracic Malignancies

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2018
immunotherapy
lung cancer
thoracic malignancies
biomarkers
PD-L1

Created: 10/20/2018 12:17:07 PM

Gilberto Lopes on NSCLC Results From the KEYNOTE-042 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO 2018
NSCLC
KEYNOTE-042
lung cancer
pembrolizumab
platinum-based chemo
chemotherapy
first-line treatment
PD-L1
tumor proportion score

Created: 6/3/2018 6:02:48 PM

Aaron Goodman, MD, on Immune Checkpoint Blockade: Clinical Implications

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO
SITC
immune checkpoint blockade
CD274
PD-L1
immunotherapy

Created: 1/28/2018 2:39:08 PM

Maria Svensson, MD, PhD Candidate, on Esophageal and Gastric Cancers: Significance of PD-1 and PD-L1 Expression

Type of Page:TapVideo
Edit This Item
Tags for this item:
Gastrointestinal Cancers Symposi
gastrointestinal cancer
esophageal cancer
gastric cancer
PD-1
PD-L1
chemotherapy-naive
adenocarcinoma
mismatched repair genes

Created: 1/22/2018 7:36:31 PM

Bernard J. Escudier, MD, on RCC: Results From the CheckMate 214 Trial

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2017
Bernard Escudier
Gustave Roussy
renal cell carcinoma
RCC
kidney cancer
CheckMate 214 trial
nivolumab
ipilimumab
sunitinib
IDMC
PD-L1

Created: 9/11/2017 9:29:07 AM

Limo Chen, PhD, on Lung Cancer and CD38: Resistance to Immunotherapy

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO-SITC 2017
Limo Chen
MD Anderson Cancer Center
lung cancer
CD38
immunotherapy
immuno-oncology
PD-L1

Created: 2/28/2017 9:34:30 AM

Rana R. McKay, MD, on RCC: Continuing Benefit After Halting Treatment

Type of Page:TapVideo
Edit This Item
Tags for this item:
GU Cancers Symposium 2017
Rana McKay
UC San Diego
renal cell carcinoma
kidney cancer
PD-1
PD-L1
immune-related adverse events
halting treatment

Created: 2/21/2017 3:15:55 PM

Martin Reck, MD, PhD, on NSCLC: Results of KEYNOTE-024 (German Language Version)

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Martin Reck
LungenClinic
pembrolizumab
platinum-based chemotherapy
first-line therapy
NSCLC
non-small cell lung cancer
lung cancer
advanced lung cancer
PD-L1
tumor proportion score

Created: 10/18/2016 4:14:19 PM

Martin Reck, MD, PhD, on NSCLC: Results of KEYNOTE-024

Type of Page:TapVideo
Edit This Item
Tags for this item:
ESMO 2016
Martin Reck
LungenClinic
pembrolizumab
platinum-based chemotherapy
first-line therapy
NSCLC
non-small cell lung cancer
lung cancer
advanced lung cancer
PD-L1
tumor proportion score

Created: 10/10/2016 10:51:34 AM

Jedd Wolchok, MD, PhD, and Anthony J. Olszanski, RPh, MD, on Results From the Checkmate 067 Trial on Nivolumab, Ipilimumab, and Advanced Melanoma

Type of Page:TapVideo
Edit This Item
Tags for this item:
Jedd Wolchok
Memorial Sloan Kettering
Anthony Olszanski
Fox Chase Cancer Center
ASCO
melanoma
CheckMate 67
ipilimumab
nivolumab
PD-L1
checkpoint antibodies
ASCO 2015

Created: 1/31/2016 9:02:38 AM

Jedd Wolchok, MD, PhD, Summarizes Results From the CheckMate 067 Trial in Advanced Melanoma

Type of Page:TapVideo
Edit This Item
Tags for this item:
Jedd Wolchok
Memorial Sloan Kettering
ASCO
melanoma
CheckMate 67
ipilimumab
nivolumab
PD-L1
checkpoint antibodies

Created: 1/31/2016 8:52:36 AM

Luis G. Paz-Ares, MD, PhD, Summarizes Results of the CheckMate 057 Trial on Nonsquamous Cell NSCLC

Type of Page:TapVideo
Edit This Item
Tags for this item:
ASCO
nivolumab
docetaxel
Paz-Ares
NSCLC
PD-L1
CheckMate
ASCO 2015

Created: 1/31/2016 8:46:14 AM
Order By Item Count
Order Alphabetically